Research Paper Volume 15, Issue 17 pp 8993—9021
Identification and validation of a prognostic signature of cuproptosis-related genes for esophageal squamous cell carcinoma
Figure 7. Analysis of drug sensitivity between low-and high-risk groups. (A–G) IC50 of seven drugs, including BMS.536924 (A), BMS.754807 (B), CGP.60474 (C), NVP.TAE684 (D), PF.02341066 (E), PLX4720 (F), and Sunitinib (G) differed for ESCC patients in different risk groups. (H) Difference in cuproptosis score between low- and high-risk groups in TCGA-ESCC dataset. (I) Correlations between cuproptosis score and risk score. (J) The plot showed 36 upregulated and 35 downregulated genes based on the above volcano analysis in high-risk group.